Search hospitals > New York > Rochester
Rochester Clinical Research, Inc
Claim this profileRochester, New York 14609
Global Leader in Migraine
Global Leader in Flu
Conducts research for Vestibular Migraine
Conducts research for Obesity
Conducts research for Childhood Obesity
245 reported clinical trials
8 medical researchers
Summary
Rochester Clinical Research, Inc is a medical facility located in Rochester, New York. This center is recognized for care of Migraine, Flu, Vestibular Migraine, Obesity, Childhood Obesity and other specialties. Rochester Clinical Research, Inc is involved with conducting 245 clinical trials across 223 conditions. There are 8 research doctors associated with this hospital, such as Matthew G Davis, MD, Patricia Lee, MD, Matthew Gilruth Davis, and Jonathan Goldstein.Area of expertise
1Migraine
Global Leader2Flu
Global Leaderestrogen
ER
Top PIs
Matthew G Davis, MDGSK Investigational Site2 years of reported clinical research
Studies Respiratory Syncytial Virus Infection
Studies Respiratory Syncytial Virus
21 reported clinical trials
30 drugs studied
Patricia Lee, MDCenter for Clinical Studies4 years of reported clinical research
Studies Atopic Dermatitis
Studies Urinary Tract Infection
9 reported clinical trials
10 drugs studied
Matthew Gilruth DavisRochester Clinical Research, Inc.5 years of reported clinical research
Studies Obesity
Studies Vestibular Migraine
5 reported clinical trials
4 drugs studied
Jonathan GoldsteinRochester Clinical Research3 years of reported clinical research
Studies Colitis
Studies Ulcerative Colitis
5 reported clinical trials
3 drugs studied
Clinical Trials running at Rochester Clinical Research, Inc
High Blood Pressure
Obesity
Shingles
Cardiovascular Disease
Childhood Obesity
Liver Cancer
Vestibular Migraine
Migraine
Coronavirus
COVID-19
Vicadrostat + Empagliflozin
for Type 2 Diabetes and Hypertension
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this combination to a placebo version of vicadrostat with empagliflozin. Participants are put into 2 groups randomly, which means by chance. One group takes vicadrostat and empagliflozin tablets, and the other group takes placebo tablets with empagliflozin. Placebo tablets look like vicadrostat tablets but do not contain any medicine. Participants take a tablet once per day for 2 and a half years and up to 4 years and 3 months. All participants also continue their medication for type 2 diabetes, high blood pressure, and cardiovascular disease. Participants have an equal chance of receiving the study medicine or placebo. Participants are in the study for up to 4 years and 3 months. During this time, they visit the study site regularly. During these visits, doctors collect information about participants' health and take blood samples. The doctors document when participants experience cardiovascular events. The doctors also regularly check participants' health and take note of any unwanted effects.
Recruiting1 award Phase 34 criteria
Orforglipron
for High Blood Pressure
GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
Recruiting1 award Phase 3
Orforglipron
for Hypertension
The GZPL master protocol will support 2 independent studies, J2A-MC-GZL1 (GZL1) and J2A-MC-GZL2 (GZL2). The purpose of this study is to create a framework to evaluate the safety and efficacy of orforglipron for the treatment of hypertension in participants with obesity or overweight.
Recruiting1 award Phase 32 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rochester Clinical Research, Inc?
Rochester Clinical Research, Inc is a medical facility located in Rochester, New York. This center is recognized for care of Migraine, Flu, Vestibular Migraine, Obesity, Childhood Obesity and other specialties. Rochester Clinical Research, Inc is involved with conducting 245 clinical trials across 223 conditions. There are 8 research doctors associated with this hospital, such as Matthew G Davis, MD, Patricia Lee, MD, Matthew Gilruth Davis, and Jonathan Goldstein.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.